Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MacroGenics Inc (NASDAQ:MGNX)

19.48
Delayed Data
As of 3:59pm ET
 +0.36 / +1.88%
Today’s Change
16.75
Today|||52-Week Range
33.30
-4.70%
Year-to-Date
No recent news for MacroGenics Inc.

Today’s Trading

Previous close19.12
Today’s open19.12
Day’s range18.89 - 19.59
Volume144,285
Average volume (3 months)240,978
Market cap$669.4M
Dividend yield--
Data as of 3:59pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)-168.25%
Earnings growth (this year)-124.90%
Earnings growth (next 5 years)--
Revenue growth (last year)-8.90%
P/E ratioNM
Price/Sales7.72
Price/Book2.48

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp+1.72+1.79%
KERXKeryx Biopharmaceuti...+0.05+0.79%
ADROAduro Biotech Inc+0.20+2.00%
ACRSAclaris Therapeutics...-0.49-1.98%
Data as of 3:59pm ET, 05/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.81
Annual revenue (last year)$91.9M
Annual profit (last year)-$58.5M
Net profit margin-63.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott E. Koenig
Chief Financial Officer, Secretary &
Senior VP
James Karrels
Corporate headquarters
Rockville, Maryland

Forecasts